Quoin Pharmaceuticals Number Of Shares Shorted vs. Shares Owned By Insiders

QNRX Stock  USD 0.66  0  0.30%   
Based on Quoin Pharmaceuticals' profitability indicators, Quoin Pharmaceuticals Ltd may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Quoin Pharmaceuticals' ability to earn profits and add value for shareholders. Price To Sales Ratio is likely to drop to -45.87 in 2024. Days Sales Outstanding is likely to drop to -71.21 in 2024. At this time, Quoin Pharmaceuticals' Net Interest Income is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 750 K in 2024, despite the fact that Operating Income is likely to grow to (8.9 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin1.11.3
Fairly Down
Very volatile
For Quoin Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Quoin Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Quoin Pharmaceuticals Ltd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Quoin Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Quoin Pharmaceuticals Ltd over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quoin Pharmaceuticals. If investors know Quoin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quoin Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.66)
Return On Assets
(0.36)
Return On Equity
(1.00)
The market value of Quoin Pharmaceuticals is measured differently than its book value, which is the value of Quoin that is recorded on the company's balance sheet. Investors also form their own opinion of Quoin Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Quoin Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quoin Pharmaceuticals' market value can be influenced by many factors that don't directly affect Quoin Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quoin Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quoin Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quoin Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Quoin Pharmaceuticals Shares Owned By Insiders vs. Number Of Shares Shorted Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Quoin Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Quoin Pharmaceuticals value to that of its competitors to determine the firm's financial worth.
Quoin Pharmaceuticals Ltd is rated below average in number of shares shorted category among its peers. It is rated below average in shares owned by insiders category among its peers . The ratio of Number Of Shares Shorted to Shares Owned By Insiders for Quoin Pharmaceuticals Ltd is about  38,995 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Quoin Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Quoin Shares Owned By Insiders vs. Number Of Shares Shorted

Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Quoin Pharmaceuticals

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
95.15 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Quoin Pharmaceuticals

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
2.44 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Quoin Shares Owned By Insiders Comparison

Quoin Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers.

Quoin Pharmaceuticals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Quoin Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Quoin Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Quoin Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Quoin Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-9.4 M-8.9 M
Income Before Tax-8.7 M-8.2 M
Net Loss-8.7 M-9.1 M
Net Interest Income616.7 K647.5 K
Net Loss-8.6 M-9.1 M
Total Other Income Expense Net714.3 K750 K
Net Loss-8.5 M-8.9 M
Income Tax Expense22.4 K23.5 K
Interest Income616.7 K647.5 K
Change To NetincomeM973.5 K
Net Loss(9.64)(9.16)
Income Quality 0.91  0.86 
Net Income Per E B T 1.00  0.65 

Quoin Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Quoin Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Quoin Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Quoin Pharmaceuticals' important profitability drivers and their relationship over time.

Use Quoin Pharmaceuticals in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Quoin Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Quoin Pharmaceuticals Pair Trading

Quoin Pharmaceuticals Ltd Pair Trading Analysis

The ability to find closely correlated positions to Quoin Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Quoin Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Quoin Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Quoin Pharmaceuticals Ltd to buy it.
The correlation of Quoin Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Quoin Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Quoin Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Quoin Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Quoin Pharmaceuticals position

In addition to having Quoin Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Monster Funds Thematic Idea Now

Monster Funds
Monster Funds Theme
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Quoin Stock Analysis

When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.